Cite
HARVARD Citation
Stutterheim, J. et al. (2021). Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol. Journal of clinical oncology. 39 (6), pp. 652-662. [Online].